KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 58 filers reported holding KRYSTAL BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $580 | -1.2% | 5 | 0.0% | 0.00% | – |
Q2 2023 | $587 | +46.8% | 5 | 0.0% | 0.00% | – |
Q1 2023 | $400 | -15.8% | 5 | -16.7% | 0.00% | – |
Q4 2022 | $475 | -52.5% | 6 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -97.8% | 6 | -99.1% | 0.00% | – |
Q4 2021 | $46,000 | -89.1% | 660 | -91.9% | 0.00% | -100.0% |
Q3 2021 | $423,000 | -96.0% | 8,111 | -94.7% | 0.00% | -94.7% |
Q2 2021 | $10,446,000 | +1.2% | 153,614 | +14.6% | 0.02% | -5.0% |
Q1 2021 | $10,323,000 | +257975.0% | 133,991 | +107957.3% | 0.02% | – |
Q1 2019 | $4,000 | -80.0% | 124 | -87.1% | 0.00% | – |
Q4 2018 | $20,000 | +17.6% | 958 | 0.0% | 0.00% | – |
Q3 2018 | $17,000 | – | 958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
Artal Group S.A. | 412,082 | $32,991 | 1.96% |
First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |